Balyasny Asset Management
GILD icon

Balyasny Asset Management’s Gilead Sciences GILD Stock Holding History

Balyasny Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Sell
9,000
-3,200
-26% -$422K ﹤0.01% 2138
2026
Q1 		$1.7M Sell
12,200
-18,300
-60% -$2.56M ﹤0.01% 1860
2025
Q4 		$3.74M Sell
30,500
-8,500
-22% -$1.03M ﹤0.01% 1544
2025
Q3 		$4.33M Buy
39,000
+4,400
+13% +$500K 0.01% 1427
2025
Q2 		$3.84M Buy
34,600
+6,600
+24% +$702K 0.01% 1413
2025
Q1 		$3.14M Sell
28,000
-43,800
-61% -$4.52M 0.01% 1476
2024
Q4 		$6.63M Sell
71,800
-53,800
-43% -$4.84M 0.01% 1137
2024
Q3 		$10.5M Buy
125,600
+93,300
+289% +$7.12M 0.02% 919
2024
Q2 		$2.22M Sell
32,300
-178,900
-85% -$11.9M ﹤0.01% 1490
2024
Q1 		$15.5M Buy
211,200
+10,900
+5% +$838K 0.03% 746
2023
Q4 		$16.2M Buy
200,300
+36,300
+22% +$2.82M 0.03% 690
2023
Q3 		$12.3M Buy
164,000
+13,000
+9% +$1,000K 0.03% 768
2023
Q2 		$11.6M Hold
151,000
– – 0.03% 711
2023
Q1 		$12.5M Sell
151,000
-12,600
-8% -$1.04M 0.03% 692
2022
Q4 		$14M Buy
163,600
+3,400
+2% +$269K 0.04% 607
2022
Q3 		$9.88M Buy
160,200
+118,300
+282% +$7.46M 0.03% 689
2022
Q2 		$2.59M Buy
+41,900
New +$2.59M 0.01% 1267
2021
Q3 		– Sell
-12,800
Closed -$881K – 2111
2021
Q2 		$881K Buy
+12,800
New +$855K ﹤0.01% 1343
2020
Q3 		– Sell
-400,000
Closed -$30.8M – 1405
2020
Q2 		$30.8M Buy
+400,000
New +$30.7M 0.27% 91
2017
Q4 		– Sell
-750,000
Closed -$60.8M – 2139
2017
Q3 		$60.8M Buy
+750,000
New +$57.4M 0.24% 101
2016
Q3 		– Sell
-150,000
Closed -$12.5M – 1098
2016
Q2 		$12.5M Buy
+150,000
New +$13.3M 0.08% 306
2015
Q3 		– Sell
-50,000
Closed -$5.85M – 1225
2015
Q2 		$5.85M Buy
+50,000
New +$5.46M 0.04% 544
2015
Q1 		– Sell
-650,000
Closed -$61.3M – 988
2014
Q4 		$61.3M Buy
650,000
+430,000
+195% +$44.5M 0.56% 30
2014
Q3 		$23.4M Buy
+220,000
New +$21.5M 0.18% 141

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Balyasny Asset Management's GILD Position: Q2 2026 in Review

Balyasny Asset Management increased its Gilead Sciences (GILD) stake by 2,869% in Q2 2026, buying an estimated $74.7M and bringing the position to 587,082 shares worth $74.2M. The position accounts for 0.09% of the portfolio, ranked #255.

Balyasny Asset Management first reported a position in GILD in Q1 2015 and has held it in 36 quarters since. The position peaked at $101M in Q1 2015. 2,290 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Balyasny Asset Management held 587,082 shares of Gilead Sciences worth $74.2M as of Q2 2026.
  • Balyasny Asset Management bought 567,308 Gilead Sciences shares in Q2 2026, an estimated $74.7M.
  • Gilead Sciences made up 0.09% of Balyasny Asset Management's portfolio in Q2 2026, its #255 holding.
  • Balyasny Asset Management first reported a position in Gilead Sciences in Q1 2015 and has held it in 36 quarters since.
  • Balyasny Asset Management's Gilead Sciences position peaked at $101M in Q1 2015.
  • 2,290 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.